Wagenaar Dirk, Langendijk Johannes A, Both Stefan
Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Phys Imaging Radiat Oncol. 2024 Dec 24;33:100691. doi: 10.1016/j.phro.2024.100691. eCollection 2025 Jan.
The McNamara (MCN) and Wedenberg (WED) RBE weighted dose (D), dose and dose-weighted average LET (LET) were calculated in twenty brain cancer patients. A linear approximation was made for each RBE model to give best agreement to clinically relevant dosimetric parameters. Additional evaluations were done on twenty head and neck and twenty breast cancer patients.The R of the fits was ≥0.94 and ≥0.91 for MCN and WED respectively for α/β values ≥1.0 Gy. The graphs derived in this work can be used to convert RBE-LET slopes derived from clinical data to α/β values in the MCN or WED models.
在20例脑癌患者中计算了麦克纳马拉(MCN)和韦登贝里(WED)相对生物效应(RBE)加权剂量(D)、剂量以及剂量加权平均传能线密度(LET)。对每个RBE模型进行线性近似,以使其与临床相关剂量学参数达到最佳拟合。对另外20例头颈癌患者和20例乳腺癌患者进行了额外评估。对于α/β值≥1.0 Gy,MCN和WED拟合的R值分别≥0.94和≥0.91。本研究得出的图表可用于将临床数据得出的RBE-LET斜率转换为MCN或WED模型中的α/β值。